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Dr. Yuanli Liu, serving on the faculty of the Department of Global Health 
and Population at Harvard School of Public Health, is founding director 
of the Harvard School of Public Health China Initiative since 2005. The 
China Initiative aims at helping advance health and social 
development in China by carrying out series of applied research studies 
targeting China’s major unresolved public health and health system 
issues, regular policy dialogues to help drawing road maps for China’s 
social sector reforms and development, and senior health executive 
education programs to help produce a critical mass of open-minded 
and well informed health sector leaders. He is also Adjunct Professor of 
Health Policy and Management at Tsinghua University and director of 
the Health and Development Institute at Tsinghua School of Public 
Policy and Management in Beijing.  Professor Liu has been teaching 
and conducting research in the areas of health policy and health 
system analysis since 1994 at Harvard, and has carried out extensive research and policy 
consultation work in many African and Asian countries. In particular, he has been closely involved in 
helping inform China’s policy making process for series of reforms and strategic developments in its 
health sector since 1993, including a 8-year survey and intervention study (1993-2001) on improving 
access to healthcare in China’s poor rural areas and the most recent work on Healthy Beijing 2020 – 
developing China’s first 10-year strategic plan for effectively combating diseases and improving 
population health. He serves on the Expert Committee of Health Policy and Management and the 
Expert Committee on Healthy China 2020, both of which are established by the Chinese Ministry of 
Health to help develop strategies for China to deal with major infectious as well as non-
communicable diseases. Dr. Liu also served on the United Nations Millennium Development 
Taskforce on HIV/AIDS, Malaria, TB, and Access to Basic Medicines.  He consulted for many 
international agencies including the World Bank, Asian Development Bank, UNDP, UNICEF, WHO as 
well as global corporations.    
 
Dr. Liu received his MD and MPH from Tongji Medical University in 1987, MS in health policy and 
management from Harvard University in 1988, and PhD in health services research, policy and 
administration from University of Minnesota in 1995. 
 
刘远立教授简介： 哈佛大学公共卫生学院中国项目部主任，博士生导师，清华大学公共管理学院卫生与发展
研究中心主任。刘远立于 1987 年获得同济医科大学医学硕士学位，1988 年获得哈佛大学科学硕士学位，
1995 年获得明尼苏达大学哲学博士学位。1994 年起任职于美国哈佛大学公共卫生学院，从事国际卫生政策与



















研究网络”。他出版过 6本中英文学术专著，在国际和国内学术期刊上发表过 100多篇论文。 刘远立教授曾经
并继续担任联合国“千年发展目标”顾问委员会委员，世界银行、亚洲开发银行、世界卫生组织、联合国儿童基
金会、联合国计划开发署、美国中华医学基金会等国际组织以及世界 500 强企业的战略顾问。 此外，刘远立
教授还是中华人民共和国卫生部卫生政策与管理专家委员会委员、“健康中国 2020”战略规划专家组成员、中
国医药卫生体制改革研究（“清华方案“）课题组组长、“健康北京 2020” 战略规划课题组组长。  
 
Lingling：The Inaugural Harvard America-China Health Summit organized by China Initiative in 
September 2011 was a great success. As the leader of this historical event, what is your vision on 
the dialogue between China and the United States? 
张玲玲：2011 年 9 月，由哈佛大学公共卫生学院中国项目部举办的首届哈佛中美健康峰会取得了巨大成功。
作为这一历史事件的领导者，您对中美之间的对话有何见解和展望？ 
 
Professor Liu: Both China and the United States, despite cultural and socioeconomic differences, 
share a common goal – to create effective, equitable and efficient health systems that increase 
access, combat disease, and improve people’s health. Recent initiatives in both countries 
demonstrate these parallel goals: between 2009 and 2010 we saw China announcing its 
ambitious Health Reform Plan and the United States passing the Patient Protection and 
Affordable Care Act (PPACA).  In the years since implementation of these policies, many 
questions, challenges and ideas have arisen; we aim to explore these in depth by organizing 
regular dialogues between health policymakers, experts and healthcare frontline leaders. I 
believe bringing together health sector leaders from our two great countries and beyond to 
share experiences and perspectives would help inform future evidence-based policy making. 









分重要的。这也是我们筹办第二次峰会的原因，该峰会将于 2012 年 10 月 31 日在北京举行。 
 
Lingling：In your report, you highlighted the common features and different characteristics of 
healthcare reforms in both countries, if each reform can only achieve one greatest 




Professor Liu: While improving health should be the ultimate goal of any health system and thus 




be summarized in three ‘A’s: Availability, Affordability and 
Appropriateness of healthcare services.  Affordability is the 
key, not only because without it people would suffer 
impoverishing effects of out-of-pocket medical expenditures, 
but also because making healthcare more affordable would 









Lingling：What is the biggest obstacle in each country's health sector reform? What experience or 
lessons they can share with each other? 
张玲玲：中美两国卫生部门改革的最大障碍是什么？有什么相互借鉴的经验或教训？ 
 
Professor Liu: I would say the biggest obstacle is resistance from the powerful interest groups. Any 
reform is about changing the status quo. Those economic and political groups, whose interests 
would be adversely affected by the reforms, cannot be expected to stay idle. For example, 
China’s “public hospital reforms” have not yet made any significant progress because public 
hospitals are not enthusiastic participants. The reform implementation process in the U.S. has 
been resisted by at least a third of the states, because the governors of those states are 
Republican, which is the opposition party running against President Obama.  It is worth noting 
that both U.S. and China included in their reform packages following common measures: 
strengthening primary care and prevention services, adoption of electronic health records, and 
provider payment reforms. The U.S. has had rich experiences in the areas of provider payment 
reforms such as DRGs and bundled payment in the context of developing “Accountable Care 
Organizations”. China’s unique heritage of traditional Chinese medicine offers alternative ways 









Lingling：We know that you have had contacts with high-level health officials in both countries. So 




Professor Liu: As the public policy maker and major implementer, government’s role in any health 
reform is of course essential. But due to different political systems of the two countries, the ways 
in which the government plays its role are different in China vs U.S. In the United States, a new 
It is worth noting that both U.S. 
and China included in their 
reform packages following 
common measures: 
strengthening primary care 
and prevention services, 
adoption of electronic health 
records, and provider payment 
reforms. 





legislation needs to be passed by the Congress in order for the reform process to be started. 
China does not need a new law, and the reforms were announced as the State Council 
“Decisions”. It is also interesting to compare different roles of the central vs local governments. 
For example, while health insurance for the poor is financed by the Federal and state 
governments in the United States, Chinese central government plays almost no role in financing 
healthcare for the poor, which is the local government’s responsibility. I like to point out that 
despite of the government’s vital role in healthcare reforms, participation of many other stake-








Lingling：No health system is perfect. In which aspects you think China surpasses the United States, 
and vice versa? 
张玲玲：任何卫生系统都不是完美的。您认为在哪些方面中国优于美国，反之亦然？ 
 
Professor Liu: China already managed to provide basic insurance coverage to over 95% of its 
population, while U.S. still has 15% of the population uninsured. This “nominal coverage” aside, 
China’s incidence rate of catastrophic medical spending (a measure of individual affordability) 
is much higher than that of the U.S. Arguably, the U.S. health system is the world’s least efficient 
system, with 18% of the GDP spent on health and medical waste being estimated to be as high 
as $750 billion in 2009. In terms of social affordability, China, with its total health spending only 




2009 年的医保估计值为 7500 亿美元。考虑社会承受能力，中国的卫生总支出只占国内生产总值的 5.1％，
是另一项优于美国的方面。 
 
Lingling：Serving as the Director of China Initiative, what was your motivation to initiate this work? 
What are the major achievements you are mostly proud of? 
张玲玲：作为中国项目部的主任，启动该项目的动机是什么？到目前为止，最引以为豪的成果是什么？ 
 
Professor Liu: I felt fortunate to be the “right person at the right time”. China Initiative at Harvard 
School of Public Health was established in the aftermath of SARS in 2005, and I have been 
serving as the founding director ever since. The mission of this initiative is to advance China’s 
health and social development by carrying out high-impact programs in education, research, 
and policy. With this multifaceted and integrated approach we aim to create sustainable and 
cost-effective changes within China’s healthcare system as well as creating lasting relationships 
between Chinese and international healthcare leaders. I am most proud of our educational 
programs, mainly because we have trained more than 400 policymakers and senior health 
executives who are now playing important roles at the national and regional levels to improve 
health of the 1.3 billion Chinese people.  Furthermore, every year during winter break since 2006 I 
had been conducting a field study course on China’s health system reforms for Harvard students 













Lingling： I learned that the Second China-U.S. Health Summit will be held in Beijing at the end of 
October this year. Would you like to share some information regarding this summit with us? 
张玲玲：第二届中美健康峰会将于今年十月底在北京举行。关于此次峰会，您有什么想与我们分享的吗？ 
 
Professor Liu: Minister CHEN Zhu and Assistant Secretary Sherry Glied, along with more than 700 
Policy makers, academic experts, and business leaders from China and elsewhere attended the 
inaugural Harvard America-China Health Summit in September, 2011 in Boston. After the first 
Summit, Minister CHEN Zhu suggested that the second Summit be held in China.  
The second Summit will take place on October 31, 2012 at the National Convention Center in 
Beijing (www.hci-bj.org).  This summit will be held at a critical juncture of development for both 
U.S. and China. While the U.S. presidential election is under way and healthcare reforms are 
again debated and even legally challenged and upheld, China, also with leadership change in 
the fall, has just begun implementing the 12th 5-Year plan after 3 years of experiences with its 
Healthcare Reform Plan. 
Based on the need assessment, the 2012 Beijing Summit is themed: “Healthcare Reforms: The 
Roles of Government, Market, and Professionalism”. In addition to senior policy makers from 
China, such as Minister Chen Zhu and Dr. Sun Zhigang, China’s national coordinator of 
healthcare reform, and from other countries, this Summit is expected to have about 800 
registered participants, including healthcare experts, senior health executives, NGO and health 
industry leaders. The Beijing Summit is co-hosted by Harvard School of Public Health, Peking 
Union Medical College, and Tsinghua School of Public Policy and Management. We are grateful 
for the enthusiastic support of the Chinese Ministry of Health and the U.S. Department of Health 
and Human Services. We are excited by the impressive set of confirmed speakers and are 
confident that you will find the presentations and discussions informative and engaging. We 
sincerely welcome your participation in this Summit to create the most memorable event 
possible with a long-lasting impact. 
 
刘教授：2011年 9月，陈竺部长和美国卫生与公共服务部副部长 Sherry Glied、以及 700多位来自中国和世
界各地的政策、学术专家和商界领袖参加于波士顿举办的首届哈佛中美健康峰会。第一次峰会后，陈竺部
长建议第二次峰会在中国举办。 














Lingling：Do you have any words for CHPAMS (China Health Policy and Management Society)? 
张玲玲：您对中国卫生政策与管理学会（海外）有什么寄语吗？ 
 
Professor Liu: I am a big fan of CHPAMS. I hope you guys can keep up the good work by serving as 
a bridge and network for sharing relevant and important information and ideas, and for 
fostering productive relationships among current and future generations of leaders in health 
policy and management research and practice. 
刘教授：我是中国卫生政策与管理学会（海外）的坚定支持者。我希望你们能保持良好的工作，发挥桥梁和纽
带作用，共享相关的、重要的信息和观点，并为促进当前和未来的几代领军人物在卫生政策与管理研究和
实践方面的协作不懈努力。 
 
  
